AU
CA
NZ
UK
US
IND
Kalkine has a fully transformed New Avatar.
Last update at 2026-03-10T16:48:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
MUCINEX CHILDREN'S LAUNCHES FIRST CHEWABLE COLD & FLU MEDICINE
Thu 07 Aug 25, 02:00 PMWe Think You Can Look Beyond Reckitt Benckiser Group's (LON:RKT) Lackluster Earnings
Mon 04 Aug 25, 02:45 PMReckitt Benckiser Group PLC (RBGLY) Is Up 11.73% in One Week: What You Should Know
Fri 01 Aug 25, 04:00 PMReckitt Benckiser Group (LON:RKT) Will Pay A Dividend Of £0.844
Sun 27 Jul 25, 07:13 AMReckitt Benckiser Shares Jump After Core Unit Beat, Guidance Upgrade
Thu 24 Jul 25, 10:43 AMReckitt to Sell Home-Care Unit Majority Stake to Advent at Up to $4.8 Billion Valuation
Fri 18 Jul 25, 09:13 AMReckitt strikes deal worth up to £3.6bn to sell Cillit Bang business
Fri 18 Jul 25, 07:56 AMReckitt sells Essential Home stake to Advent for $4.8 billion
Fri 18 Jul 25, 06:07 AMOTC Markets Group Welcomes Reckitt Benckiser Group Plc. to OTCQX
Thu 10 Jul 25, 11:00 AMSerena Williams To VCs: 'When You Invest in Women—The Returns Are There'
Sun 06 Jul 25, 12:00 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 3067.00M | -260.00000M | 1873.00M | -2107.00000M | 2722.00M |
| Minority interest | -19.00000M | -11.00000M | 44.00M | 44.00M | 47.00M |
| Net income | 2330.00M | -52.00000M | 1187.00M | -2772.00000M | 2161.00M |
| Selling general administrative | 1205.00M | 1190.00M | 1393.00M | 740.00M | 890.00M |
| Selling and marketing expenses | 3438.00M | 3460.00M | 3611.00M | 3417.00M | 3168.00M |
| Gross profit | 8361.00M | 7676.00M | 8435.00M | 7778.00M | 7635.00M |
| Reconciled depreciation | 607.00M | 481.00M | 1457.00M | 5554.00M | 350.00M |
| Ebit | 3249.00M | 3488.00M | 3145.00M | -1714.00000M | 3051.00M |
| Ebitda | 3936.00M | 3969.00M | 4602.00M | 3840.00M | 3401.00M |
| Depreciation and amortization | 687.00M | 481.00M | 1457.00M | 5554.00M | 350.00M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 3249.00M | 3488.00M | 3145.00M | -1714.00000M | 3280.00M |
| Other operating expenses | 11218.00M | 10520.00M | 10848.00M | 9684.00M | 9317.00M |
| Interest expense | 257.00M | 244.00M | 363.00M | 314.00M | 354.00M |
| Tax provision | 711.00M | -208.00000M | 720.00M | 665.00M | 536.00M |
| Interest income | 127.00M | 29.00M | 77.00M | 96.00M | 78.00M |
| Net interest income | -230.00000M | -233.00000M | -286.00000M | -178.00000M | -325.00000M |
| Extraordinary items | -7.00000M | 31.00M | 50.00M | -898.00000M | -5.00000M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 711.00M | -208.00000M | 720.00M | 665.00M | 536.00M |
| Total revenue | 14453.00M | 13234.00M | 13993.00M | 12846.00M | 12597.00M |
| Total operating expenses | 5126.00M | 4962.00M | 5290.00M | 4616.00M | 4355.00M |
| Cost of revenue | 6092.00M | 5558.00M | 5558.00M | 5068.00M | 4962.00M |
| Total other income expense net | -182.00000M | -3748.00000M | -1272.00000M | -393.00000M | -558.00000M |
| Discontinued operations | -7.00000M | 31.00M | 50.00M | -898.00000M | -5.00000M |
| Net income from continuing ops | 2356.00M | -52.00000M | 1153.00M | -2772.00000M | 2186.00M |
| Net income applicable to common shares | 2330.00M | -32.00000M | 1187.00M | -3683.00000M | 2159.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | - | 28742.00M | 26946.00M | 31292.00M | 32139.00M |
| Intangible assets | - | 14594.00M | 13540.00M | 17610.00M | 17799.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | - | 2303.00M | 2285.00M | 2212.00M | 2187.00M |
| Total liab | - | 19259.00M | 19493.00M | 22133.00M | 22732.00M |
| Total stockholder equity | - | 9443.00M | 7399.00M | 9115.00M | 9363.00M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | - | 1073.00M | 336.00M | 433.00M | 461.00M |
| Common stock | - | 74.00M | 74.00M | 74.00M | 74.00M |
| Capital stock | - | 74.00M | 74.00M | 74.00M | 74.00M |
| Retained earnings | - | 23638.00M | 22490.00M | 23397.00M | 23353.00M |
| Other liab | - | 3755.00M | 4327.00M | 5401.00M | 5256.00M |
| Good will | - | 5609.00M | 5328.00M | 5369.00M | 6462.00M |
| Other assets | - | 538.00M | 701.00M | 611.00M | 647.00M |
| Cash | - | 1157.00M | 1261.00M | 1646.00M | 1549.00M |
| Cash and equivalents | - | 1157.00M | - | - | - |
| Total current liabilities | - | 8341.00M | 8088.00M | 6938.00M | 8931.00M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | - | 7727.00M | 8302.00M | 8911.00M | 10646.00M |
| Short term debt | - | 1721.00M | 2485.00M | 763.00M | 3650.00M |
| Short long term debt | - | 1643.00M | 2423.00M | 691.00M | 3650.00M |
| Short long term debt total | - | 8884.00M | 9563.00M | 10557.00M | 12195.00M |
| Other stockholder equity | - | -14269.00000M | -15165.00000M | -14356.00000M | -14064.00000M |
| Property plant equipment | - | 2473.00M | 2178.00M | 2233.00M | 2140.00M |
| Total current assets | - | 5285.00M | 5005.00M | 5314.00M | 5033.00M |
| Long term investments | - | - | - | - | 58.00M |
| Net tangible assets | - | -10760.00000M | -11469.00000M | -13864.00000M | -14898.00000M |
| Short term investments | - | - | 674.00M | 1147.00M | 1006.00M |
| Net receivables | - | 2082.00M | 2081.00M | 1972.00M | 2060.00M |
| Long term debt | - | 6852.00M | 6812.00M | 9553.00M | 8292.00M |
| Inventory | - | 1825.00M | 1459.00M | 1592.00M | 1314.00M |
| Accounts payable | - | 5547.00M | 5267.00M | 5742.00M | 4820.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | - | 537.00M | 698.00M | 508.00M | 481.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | - | 23457.00M | 21941.00M | 25978.00M | 27106.00M |
| Capital lease obligations | - | 389.00M | 328.00M | 313.00M | 253.00M |
| Long term debt total | - | 7163.00M | 7078.00M | 9794.00M | 8545.00M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -139.00000M | -27.00000M | -36.00000M | -18.00000M | -9.00000M |
| Change to liabilities | -145.00000M | -126.00000M | 1145.00M | 31.00M | 81.00M |
| Total cashflows from investing activities | -139.00000M | 239.00M | -512.00000M | -442.00000M | -422.00000M |
| Net borrowings | -1533.00000M | -1006.00000M | -1680.00000M | 426.00M | -1617.00000M |
| Total cash from financing activities | -2380.00000M | -2286.00000M | -2857.00000M | -830.00000M | -2618.00000M |
| Change to operating activities | - | - | - | - | - |
| Net income | 3067.00M | -804.00000M | 2160.00M | -1954.00000M | 2161.00M |
| Change in cash | -103.00000M | -385.00000M | 97.00M | 70.00M | -640.00000M |
| Begin period cash flow | 1259.00M | 1644.00M | 1547.00M | 1477.00M | 2117.00M |
| End period cash flow | 1156.00M | 1259.00M | 1644.00M | 1547.00M | 1477.00M |
| Total cash from operating activities | 2397.00M | 1697.00M | 3518.00M | 1411.00M | 2454.00M |
| Issuance of capital stock | 54.00M | 80.00M | 131.00M | 61.00M | 105.00M |
| Depreciation | 607.00M | 481.00M | 1457.00M | 5554.00M | 350.00M |
| Other cashflows from investing activities | 304.00M | 689.00M | -26.00000M | 1.00M | 15.00M |
| Dividends paid | 1249.00M | 1246.00M | 1241.00M | 1227.00M | 1187.00M |
| Change to inventory | -254.00000M | -57.00000M | -317.00000M | -87.00000M | -68.00000M |
| Change to account receivables | -23.00000M | -130.00000M | 94.00M | -150.00000M | -103.00000M |
| Sale purchase of stock | 54.00M | -5.00000M | -4.00000M | 1533.00M | 105.00M |
| Other cashflows from financing activities | 2622.00M | -71.00000M | 2844.00M | -75.00000M | 708.00M |
| Change to netincome | 52.00M | 1561.00M | 939.00M | 4785.00M | 52.00M |
| Capital expenditures | 443.00M | 450.00M | 486.00M | 443.00M | 437.00M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -422.00000M | -313.00000M | 922.00M | -206.00000M | -90.00000M |
| Stock based compensation | 78.00M | 30.00M | 15.00M | 18.00M | 14.00M |
| Other non cash items | -933.00000M | 2303.00M | -1036.00000M | -2001.00000M | 19.00M |
| Free cash flow | 1954.00M | 1247.00M | 3032.00M | 968.00M | 2017.00M |
Sector: Consumer Defensive Industry: Household & Personal Products
| Company | Change (GBX) | Price (GBX) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| RKT Reckitt Benckiser Group PLC |
- -% | 5482.00 | 17.55 | 15.29 | 2.58 | 4.22 | 3.09 | 11.89 |
| ULVR Unilever PLC |
- -% | 4907.00 | 13.43 | 15.55 | 1.56 | 5.66 | 1.87 | 8.08 |
| PZC PZ Cussons PLC |
- -% | 78.00 | 16.93 | - | 1.01 | 1.68 | 1.02 | 7.20 |
| W7L Warpaint London PLC |
4.00 1.82% | 224.00 | 32.95 | - | 3.81 | 6.31 | 3.56 | 19.81 |
| MCB McBride plc |
- -% | 146.60 | - | 5.85 | 0.16 | 4.16 | 0.36 | 16.20 |
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands. The company also offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; fabric washing; and other hygiene products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides vitamins, minerals, and supplements under the Biofreeze, Airborne, Mead Johnson, Move Free, Enfamil, Neuriva, and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.
Turner House, Slough, United Kingdom, SL1 3UH
| Name | Title | Year Born |
|---|---|---|
| Mr. Nicandro Durante | CEO & Director | 1956 |
| Mr. Jeffrey Carr ACMA, B.Eng | Group CFO & Exec. Director | 1961 |
| Mr. Filippo Catalano | Chief Information & Digitisation Officer | NA |
| Mr. Richard Joyce | Head of Investor Relations | NA |
| Ms. Catheryn O'Rourke | Sr. VP, Gen. Counsel & Company Sec. | NA |
| Mr. Fabrice Beaulieu | Chief Marketing, Sustainability & Corp. Affairs Officer | NA |
| Mr. Ranjay Radhakrishnan | Chief HR Officer | NA |
| Mr. Kris Licht | Pres of Health & Chief Customer Officer | NA |
| Mr. John Dawson | Sr. VP of Investor Relations | NA |
| Mr. Sami Naffakh | Chief Supply Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...